These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10229064)

  • 61. Lorazepam use and catatonic syndrome.
    Peterson GN
    J Clin Psychopharmacol; 1985 Dec; 5(6):359-60. PubMed ID: 4067005
    [No Abstract]   [Full Text] [Related]  

  • 62. Lorazepam monotherapy for catatonic stupor.
    Ungvari GA; Rankin JF
    J Clin Psychopharmacol; 1989 Apr; 9(2):154. PubMed ID: 2723137
    [No Abstract]   [Full Text] [Related]  

  • 63. Relapses and recurrences of catatonia: 30-case analysis and literature review.
    Lin CC; Hung YY; Tsai MC; Huang TL
    Compr Psychiatry; 2016 Apr; 66():157-65. PubMed ID: 26995249
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Benzodiazepine monotherapy in acute schizophrenia].
    Jaspert A; Ebert D
    Nervenarzt; 1994 Jan; 65(1):62-5. PubMed ID: 7908419
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lorazepam, a new benzodiazepine derivative, in the treatment of anxiety: a double-blind clinical evaluation.
    McCurdy L
    Am J Psychiatry; 1979 Feb; 136(2):187-90. PubMed ID: 32776
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Revisiting lorazepam challenge test: Clinical response with dose variations and utility for catatonia in a psychiatric emergency setting.
    Suchandra HH; Reddi VSK; Aandi Subramaniyam B; Muliyala KP
    Aust N Z J Psychiatry; 2021 Oct; 55(10):993-1004. PubMed ID: 33124447
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.
    Ohi K; Kuwata A; Shimada T; Yasuyama T; Nitta Y; Uehara T; Kawasaki Y
    Medicine (Baltimore); 2017 Apr; 96(16):e6566. PubMed ID: 28422845
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Attributions to new onset catatonic symptoms, late in the course of chronic schizophrenia.
    Kar SK; Srivastava A
    Asian J Psychiatr; 2017 Dec; 30():44-46. PubMed ID: 28738260
    [No Abstract]   [Full Text] [Related]  

  • 69. A16-year-old girl with excited catatonia treated with low-dose oral Lorazepam.
    Pruett JR; Rizvi ST
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):1005-10. PubMed ID: 16379521
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Temporal glioblastoma presenting as catatonia.
    Franssen A; Sienaert P
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30837231
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
    Berkowitz JM
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effect of lorazepam on pain and anxiety in abortion.
    Wiebe E; Podhradsky L; Dijak V
    Contraception; 2003 Mar; 67(3):219-21. PubMed ID: 12618257
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Catatonia in the ICU: an important and underdiagnosed cause of altered mental status. a case series and review of the literature*.
    Saddawi-Konefka D; Berg SM; Nejad SH; Bittner EA
    Crit Care Med; 2014 Mar; 42(3):e234-41. PubMed ID: 24275514
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Catatonia in Ugandan children with nodding syndrome and effects of treatment with lorazepam: a pilot study.
    Kakooza-Mwesige A; Dhossche DM; Idro R; Akena D; Nalugya J; Opar BT
    BMC Res Notes; 2015 Dec; 8():825. PubMed ID: 26710961
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'): I. Demographic and clinical correlates in the chronic phase.
    Ungvari GS; Leung SK; Ng FS; Cheung HK; Leung T
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):27-38. PubMed ID: 15610942
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Double-blind controlled trial comparing alprazolam and lorazepam in ambulatory anxious patients].
    Hecquet S; Puech AJ; Lecrubier Y
    Therapie; 1984; 39(3):253-61. PubMed ID: 6147031
    [No Abstract]   [Full Text] [Related]  

  • 78. Treatment of catatonia with olanzapine and amantadine.
    Babington PW; Spiegel DR
    Psychosomatics; 2007; 48(6):534-6. PubMed ID: 18071103
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
    Woelk H; Schläfke S
    Phytomedicine; 2010 Feb; 17(2):94-9. PubMed ID: 19962288
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.